Eton Pharmaceuticals Inc (ETON)
NASDAQ
The current ETON market cap is 290.14M. The company's latest EPS is USD -0.0362 and P/E is -309.67.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 12M | 7.03M | 7.31M | 7.97M | 9.07M |
Operating Income | 3.88M | -548k | -1.99M | -800k | -2.94M |
Net Income | 4.56M | -579k | -2.26M | -811k | -3.04M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 959k | 39k | 21.83M | 21.25M | 31.64M |
Operating Income | -18.6M | -27.11M | -1.5M | -8.26M | -1.19M |
Net Income | -18.32M | -27.97M | -1.96M | -9.02M | -936k |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 30.93M | 31.53M | 31.74M | 30.79M | 31.82M |
Total Liabilities | 14.21M | 14.63M | 16.26M | 15.3M | 18.36M |
Total Equity | 16.73M | 16.89M | 15.48M | 15.49M | 13.46M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 17.07M | 26.32M | 27.47M | 25.03M | 31.74M |
Total Liabilities | 6.52M | 10.66M | 9.84M | 11.95M | 16.26M |
Total Equity | 10.55M | 15.66M | 17.63M | 13.08M | 15.48M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 5.56M | 6.43M | 6.82M | -2.47M | -1.22M |
Investing | N/A | N/A | -775k | -1.88M | -1.88M |
Financing | -295k | -663k | -957k | -378k | -594k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -18.03M | -22.35M | -4.51M | 4.82M | 6.82M |
Investing | -1.85M | -50k | -2.56M | -2.79M | -775k |
Financing | 5.2M | 31.63M | 391k | -134k | -957k |
Market Cap | 290.14M |
Price to Earnings Ratio | -309.67 |
Price to Sales Ratio | 9.15 |
Price to Cash Ratio | 13.54 |
Price to Book Ratio | 18.71 |
Dividend Yield | - |
Shares Outstanding | 25.84M |
Average Volume (1 week) | 296.92k |
Average Volume (1 Month) | 238.18k |
52 Week Change | 215.45% |
52 Week High | 11.23 |
52 Week Low | 3.03 |
Spread (Intraday) | 0.63 (5.41%) |
Company Name | Eton Pharmaceuticals Inc |
Address |
850 new burton road dover, delaware 19904 |
Website | https://www.etonpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.